Results 231 to 240 of about 32,756 (253)

Comparison of the Effects of Glucagon-Like Peptide Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors for Prevention of Major Adverse Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus

Circulation, 2019
Thomas A Zelniker, Itamar Raz, Kyungah Im   +2 more
exaly  

Cardiovascular safety and glycemic control of glucagon-like peptide-1 receptor agonists for type 2 diabetes mellitus: A pairwise and network meta-analysis

Diabetes Research and Clinical Practice, 2012
Feng Sun, Siyan Zhan
exaly  

Effects of glucagon-like peptide-1 receptor agonists on major cardiovascular events in patients with Type 2 diabetes mellitus with or without established cardiovascular disease: a meta-analysis of randomized controlled trials

European Heart Journal, 2020
Fabio Marsico, Dario Bruzzese, Simona Dell'Aversana   +2 more
exaly  

Glucagon-Like Peptide-1 Receptor Agonists and Osteoarthritis

New England Journal of Medicine
openaire   +2 more sources

Glucagon-Like Peptide-1 Receptor Agonists Increase Pancreatic Mass by Induction of Protein Synthesis

Diabetes, 2015
Jacqueline A Koehler, Laurie L Baggio, Xiemin Cao   +2 more
exaly  

Glucagon-like peptide-1 receptor agonists and acute pancreatitis

Diabetes & Metabolism
Kuan-Fu, Liao, Shih-Wei, Lai
openaire   +2 more sources

[Glucagon-like peptide-1 receptor agonists].

Nihon rinsho. Japanese journal of clinical medicine, 2012
Takeshi, Kurose, Yutaka, Seino
openaire   +1 more source

Glucagon‐like peptide‐1 receptor agonists: a narrative review of clinical pharmacology and implications for peri‐operative practice

Anaesthesia
Sophie S Liang, Peter C A Kam
exaly  

Association between glucagon-like peptide-1 receptor agonists use and change in alcohol consumption: a systematic review

EClinicalMedicine
Mohsan Subhani, Guruprasad P Aithal
exaly  

Glucagon-Like Peptide-1 Receptor Agonists and Cancer—Reply

JAMA Oncology
Hao, Dai, Jingchuan, Guo, Jiang, Bian
openaire   +2 more sources